{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T15:19:01Z","timestamp":1775920741326,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["CCR17480662"],"award-info":[{"award-number":["CCR17480662"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10549-022-06739-5","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T16:09:25Z","timestamp":1663862965000},"page":"389-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer"],"prefix":"10.1007","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3068-2669","authenticated-orcid":false,"given":"Anne Marie","family":"McCarthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisa K.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Welch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Moy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance D.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"issue":"10","key":"6739_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.7326\/0003-4819-151-10-200911170-00009","volume":"151","author":"HD Nelson","year":"2009","unstructured":"Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L (2009) Screening for breast cancer: an update for the U.S. preventive services task force. Ann Intern Med 151(10):727\u2013737","journal-title":"Ann Intern Med"},{"issue":"3","key":"6739_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2214\/AJR.14.13904","volume":"205","author":"LM Henderson","year":"2015","unstructured":"Henderson LM, Miglioretti DL, Kerlikowske K, Wernli KJ, Sprague BL, Lehman CD (2015) breast cancer characteristics associated with digital versus film-screen mammography for screen-detected and interval cancers. AJR Am J Roentgenol 205(3):676\u2013684","journal-title":"AJR Am J Roentgenol"},{"key":"6739_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw290","author":"Y Shieh","year":"2017","unstructured":"Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, Ziv E, Van\u2019t Veer LJ, Esserman LJ, Tice JA (2017) Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djw290","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"6739_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/jamaoncol.2019.3820","volume":"6","author":"GL Gierach","year":"2020","unstructured":"Gierach GL, Choudhury PP, Garc\u00eda-Closas M (2020) Toward risk-stratified breast cancer screening: considerations for changes in screening guidelines. JAMA Oncol 6(1):31\u201333","journal-title":"JAMA Oncol"},{"issue":"22","key":"6739_CR5","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1903986","volume":"381","author":"MF Bakker","year":"2019","unstructured":"Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, Emaus MJ, Loo CE, Bisschops RHC, Lobbes MBI et al (2019) Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 381(22):2091\u20132102","journal-title":"N Engl J Med"},{"issue":"4","key":"6739_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1200\/JCO.2014.56.6232","volume":"33","author":"XA Phi","year":"2015","unstructured":"Phi XA, Houssami N, Obdeijn IM, Warner E, Sardanelli F, Leach MO, Riedl CC, Trop I, Tilanus-Linthorst MM, Mandel R et al (2015) Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age \u2265 50 years: evidence from an individual patient data meta-analysis. J Clin Oncol 33(4):349\u2013356","journal-title":"J Clin Oncol"},{"issue":"13","key":"6739_CR7","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1200\/JCO.2009.27.0835","volume":"29","author":"E Warner","year":"2011","unstructured":"Warner E, Hill K, Causer P, Plewes D, Jong R, Yaffe M, Foulkes WD, Ghadirian P, Lynch H, Couch F et al (2011) Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol 29(13):1664\u20131669","journal-title":"J Clin Oncol"},{"issue":"4","key":"6739_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M15-1789","volume":"164","author":"J Melnikow","year":"2016","unstructured":"Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K (2016) Supplemental screening for breast cancer in women with dense breasts: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 164(4):268\u2013278","journal-title":"Ann Intern Med"},{"issue":"4","key":"6739_CR9","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.ajpath.2013.07.003","volume":"183","author":"M Ghoussaini","year":"2013","unstructured":"Ghoussaini M, Pharoah PDP, Easton DF (2013) Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning? Am J Pathol 183(4):1038\u20131051","journal-title":"Am J Pathol"},{"issue":"7678","key":"6739_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou K, Lindstr\u00f6m S, Dennis J, Beesley J, Hui S, Kar S, Lema\u00e7on A, Soucy P, Glubb D, Rostamianfar A et al (2017) Association analysis identifies 65 new breast cancer risk loci. Nature 551(7678):92\u201394","journal-title":"Nature"},{"issue":"12","key":"6739_CR11","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1038\/ng.3785","volume":"49","author":"RL Milne","year":"2017","unstructured":"Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindstr\u00f6m S, Hui S, Lema\u00e7on A, Soucy P, Dennis J et al (2017) Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat Genet 49(12):1767\u20131778","journal-title":"Nat Genet"},{"issue":"1","key":"6739_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","volume":"104","author":"N Mavaddat","year":"2019","unstructured":"Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK et al (2019) Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet 104(1):21\u201334","journal-title":"Am J Hum Genet"},{"issue":"4","key":"6739_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1158\/1055-9965.EPI-17-1144","volume":"27","author":"J Lilyquist","year":"2018","unstructured":"Lilyquist J, Ruddy KJ, Vachon CM, Couch FJ (2018) Common genetic variation and breast cancer risk-past, present, and future. Cancer Epidemiol Biomarkers Prev 27(4):380\u2013394","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"6739_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/jnci\/djaa056","volume":"113","author":"PM Kapoor","year":"2021","unstructured":"Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindstr\u00f6m S, Behrens S, Michailidou K, Dennis J, Bolla MK, Wang Q et al (2021) Combined associations of a polygenic risk score and classical risk factors with breast cancer risk. J Natl Cancer Inst 113(3):329\u2013337","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"6739_CR15","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/jnci\/djaa176","volume":"113","author":"K Kerlikowske","year":"2021","unstructured":"Kerlikowske K, Bissell MCS, Sprague BL, Buist DSM, Henderson LM, Lee JM, Miglioretti DL (2021) Advanced breast cancer definitions by staging system examined in the breast cancer surveillance consortium. J Natl Cancer Inst 113(7):909\u2013916","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"6739_CR16","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1002\/cncr.33661","volume":"127","author":"AM McCarthy","year":"2021","unstructured":"McCarthy AM, Ehsan S, Appel S, Welch M, He W, Bahl M, Chen J, Lehman CD, Armstrong K (2021) Risk factors for an advanced breast cancer diagnosis within 2 years of a negative mammogram. Cancer 127(18):3334\u20133342","journal-title":"Cancer"},{"issue":"3","key":"6739_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/jnci\/djaa056","volume":"113","author":"PM Kapoor","year":"2021","unstructured":"Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindstrom S, Behrens S, Michailidou K, Dennis J, Bolla MK, Wang Q et al (2021) Combined associations of a polygenic risk score and classical risk factors with breast cancer risk. J Natl Cancer Inst 113(3):329\u2013337","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"6739_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1200\/JCO.2015.63.0624","volume":"34","author":"J Holm","year":"2016","unstructured":"Holm J, Li J, Darabi H, Eklund M, Eriksson M, Humphreys K, Hall P, Czene K (2016) Associations of breast cancer risk prediction tools with tumor characteristics and metastasis. J Clin Oncol 34(3):251\u2013258","journal-title":"J Clin Oncol"},{"issue":"2","key":"6739_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1148\/radiol.2020201620","volume":"297","author":"M Eriksson","year":"2020","unstructured":"Eriksson M, Czene K, Strand F, Zackrisson S, Lindholm P, L\u00e5ng K, F\u00f6rnvik D, Sartor H, Mavaddat N, Easton D et al (2020) Identification of women at high risk of breast cancer who need supplemental screening. Radiology 297(2):327\u2013333","journal-title":"Radiology"},{"issue":"3","key":"6739_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/annonc\/mdu565","volume":"26","author":"J Li","year":"2015","unstructured":"Li J, Holm J, Bergh J, Eriksson M, Darabi H, Lindstr\u00f6m LS, T\u00f6rnberg S, Hall P, Czene K (2015) Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers. Ann Oncol 26(3):517\u2013522","journal-title":"Ann Oncol"},{"issue":"1","key":"6739_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10549-019-05210-2","volume":"176","author":"DGR Evans","year":"2019","unstructured":"Evans DGR, Harkness EF, Brentnall AR, van Veen EM, Astley SM, Byers H, Sampson S, Southworth J, Stavrinos P, Howell SJ et al (2019) Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants. Breast Cancer Res Treat 176(1):141\u2013148","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"6739_CR22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/jnci\/djaa127","volume":"113","author":"JJ van den Broek","year":"2021","unstructured":"van den Broek JJ, Schechter CB, van Ravesteyn NT, Janssens A, Wolfson MC, Trentham-Dietz A, Simard J, Easton DF, Mandelblatt JS, Kraft P et al (2021) Personalizing breast cancer screening based on polygenic risk and family History. J Natl Cancer Inst 113(4):434\u2013442","journal-title":"J Natl Cancer Inst"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06739-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06739-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06739-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T21:08:48Z","timestamp":1666213728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06739-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["6739"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06739-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"15 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Lehman reports that her institution, Massachusetts General Hospital, receives research support from GE Healthcare and Hologic, Inc. and that she is a co-founder and serves as a consultant to Clairity, Inc. The other authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors confirm that human research participants provided informed consent for their genetic information and data to be used for research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal rights"}}]}}